Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey

Publisher: Karger

E-ISSN: 1421-9875|35|5|423-432

ISSN: 0257-2753

Source: Digestive Diseases, Vol.35, Iss.5, 2017-06, pp. : 423-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content